(Q35145063)

6 August 2017

1 reference

title

Review article: natural history and prognostic prediction of patients with hepatocellular carcinoma (English)

1 reference

6 August 2017

1 reference

3

Llovet JM

1 reference

6 August 2017

Varela M

1

1 reference

6 August 2017

Sala M

series ordinal

2

1 reference

6 August 2017

Bruix J

series ordinal

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Alimentary Pharmacology & Therapeutics

6 August 2017

published in

1 reference

6 August 2017

volume

17 Suppl 2

1 reference

6 August 2017

page(s)

98-102

1 reference

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.11.X

21 January 2018

Hepatobiliary surgery

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.11.X

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.11.X

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.11.X

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.11.X

Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.11.X

Performance status assessment in cancer patients. An inter-observer variability study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.11.X

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.11.X

Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.11.X

Predictive factors for postoperative recurrence of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.11.X

Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.11.X

10.1046/J.1365-2036.17.S2.11.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference